Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 4802319, 10 pages
https://doi.org/10.1155/2017/4802319
Research Article

Upregulation of Tumor Necrosis Factor-α-Induced Protein 8-Like 2 mRNA Is Negatively Correlated with Serum Concentrations of Tumor Necrosis Factor-α and Interleukin 6 in Type 2 Diabetes Mellitus

1Central of Translation Medicine, Zibo Central Hospital Affiliated to Shandong University, Zibo 255036, China
2Department of Pathology, Zibo Central Hospital Affiliated to Shandong University, Zibo 255036, China
3Department of Central Laboratory, Zibo Central Hospital Affiliated to Shandong University, Zibo 255036, China

Correspondence should be addressed to Xinxin Xiang; nc.ude.umjb@nixnixgnaix and Tao Li; moc.361@ykyyxzsbz

Received 2 December 2016; Revised 4 March 2017; Accepted 4 April 2017; Published 24 May 2017

Academic Editor: Lucy Marzban

Copyright © 2017 Yongliang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Defronzo, “Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus,” Diabetes, vol. 58, no. 4, pp. 773–795, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Vandanmagsar, Y. H. Youm, A. Ravussin et al., “The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance,” Nature Medicine, vol. 17, no. 2, pp. 179–188, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. K. Tan, N. Leuenberger, M. J. Tan et al., “Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet,” Diabetes, vol. 60, no. 2, pp. 464–476, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. C. Calle and M. L. Fernandez, “Inflammation and type 2 diabetes,” Diabetes & Metabolism, vol. 38, no. 3, pp. 183–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. N. N. Mehta, F. C. McGillicuddy, P. D. Anderson et al., “Experimental endotoxemia induces adipose inflammation and insulin resistance in humans,” Diabetes, vol. 59, no. 1, pp. 172–181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Hirosumi, G. Tuncman, L. Chang et al., “A central role for JNK in obesity and insulin resistance,” Nature, vol. 420, no. 6913, pp. 333–336, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. E. S. Yeo, J. Y. Hwang, J. E. Park, Y. J. Choi, K. B. Huh, and W. Y. Kim, “Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes,” Yonsei Medical Journal, vol. 51, no. 4, pp. 519–525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Banerjee and M. Saxena, “Interleukin-1 (IL-1) family of cytokines: role in type 2 diabetes,” Clinica Chimica Acta, vol. 413, no. 15-16, pp. 1163–1170, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Zhao, H. Wang, T. Li et al., “Increased T cell immunoglobulin and mucin domain containing 4 (TIM-4) is negatively correlated with serum concentrations of interleukin-1beta in type 2 diabetes,” Journal of Diabetes, vol. 8, no. 2, pp. 199–205, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Cutando, J. Montero, R. Gomez-de Diego, M. J. Ferrera, and A. Lopez-Valverde, “Effect of topical application of melatonin on serum levels of C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) in patients with type 1 or type 2 diabetes and periodontal disease,” Journal of Clinical and Experimental Dentistry, vol. 7, no. 5, pp. e628–e633, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. G. S. Hotamisligil, A. Budavari, D. Murray, and B. M. Spiegelman, “Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha,” Journal of Clinical Investigation, vol. 94, no. 4, pp. 1543–1549, 1994. View at Publisher · View at Google Scholar
  12. P. Peraldi, G. S. Hotamisligil, W. A. Buurman, M. F. White, and B. M. Spiegelman, “Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase,” Journal of Biological Chemistry, vol. 271, no. 22, pp. 13018–13022, 1996. View at Google Scholar
  13. H. Ruan, N. Hacohen, T. R. Golub, L. Van Parijs, and H. F. Lodish, “Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory,” Diabetes, vol. 51, no. 5, pp. 1319–1336, 2002. View at Publisher · View at Google Scholar
  14. H. Sun, S. Gong, R. J. Carmody et al., “TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis,” Cell, vol. 133, no. 3, pp. 415–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. E. C. Freundt, N. Bidere, and M. J. Lenardo, “A different TIPE of immune homeostasis,” Cell, vol. 133, no. 3, pp. 401-402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. X. Zhang, J. Wang, C. Fan et al., “Crystal structure of TIPE2 provides insights into immune homeostasis,” Nature Structural & Molecular Biology, vol. 16, no. 1, pp. 89-90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Li, L. Song, Y. Fan et al., “Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus,” Clinical Immunology, vol. 133, no. 3, pp. 422–427, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Xi, Y. Hu, Y. Liu et al., “Roles of TIPE2 in hepatitis B virus-induced hepatic inflammation in humans and mice,” Molecular Immunology, vol. 48, no. 9-10, pp. 1203–1208, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ma, X. Liu, Z. Wei et al., “The expression and significance of TIPE2 in peripheral blood mononuclear cells from asthmatic children,” Scandinavian Journal of Immunology, vol. 78, no. 6, pp. 523–528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Zhang, Y. Zhang, X. Wei et al., “Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy,” Biochimica et Biophysica Acta, vol. 1802, no. 11, pp. 1078–1086, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Jia, B. Gui, P. Tian et al., “TIPE2, a novel biomarker for clinical chronic kidney allograft rejection,” Artificial Organs, vol. 37, no. 2, pp. 221–225, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Xiang, H. Lan, H. Tang et al., “Tuberous sclerosis complex 1-mechanistic target of rapamycin complex 1 signaling determines brown-to-white adipocyte phenotypic switch,” Diabetes, vol. 64, no. 2, pp. 519–528, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhang, X. Wei, L. Liu et al., “TIPE2, a novel regulator of immunity, protects against experimental stroke,” Journal of Biological Chemistry, vol. 287, no. 39, pp. 32546–32555, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Khodabandehloo, S. Gorgani-Firuzjaee, G. Panahi, and R. Meshkani, “Molecular and cellular mechanisms linking inflammation to insulin resistance and beta-cell dysfunction,” Translational Research, vol. 167, no. 1, pp. 228–256, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Y. Nowlin, M. J. Hammer, and G. D'Eramo Melkus, “Diet, inflammation, and glycemic control in type 2 diabetes: an integrative review of the literature,” Journal of Nutrition and Metabolism, vol. 2012, Article ID 542698, p. 21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Y. Donath, D. J. Gross, E. Cerasi, and N. Kaiser, “Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes,” Diabetes, vol. 48, no. 4, pp. 738–744, 1999. View at Publisher · View at Google Scholar
  27. A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler, “Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes,” Diabetes, vol. 52, no. 1, pp. 102–110, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. C. M. Parrinello and E. Selvin, “Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management,” Current Diabetes Reports, vol. 14, no. 11, p. 548, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Acuna, P. Sanchez, L. Soler, and L. F. Alvis, “Total cholesterol (Tc), low-density lipoprotein cholesterol (Ldl-C) and high-density lipoprotein cholesterol (Hdl-C) levels in patients with hypertension (ht), diabetes (Dm), both (Ht and Dm) and chronic kidney disease (Ckd),” Value in Health, vol. 18, no. 7, pp. A405–A406, 2015. View at Publisher · View at Google Scholar
  30. T. Higgins, “HbA1c for screening and diagnosis of diabetes mellitus,” Endocrine, vol. 43, no. 2, pp. 266–273, 2013. View at Publisher · View at Google Scholar · View at Scopus